Cargando…

Low incidence of HCC in chronic hepatitis C patients with pretreatment liver stiffness measurements below 17.5 kilopascal who achieve SVR following DAAs

BACKGROUND AND AIMS: To evaluate the ability of pretreatment liver stiffness measurements (pLSM) to predict hepatocellular carcinoma (HCC), incident decompensation and all-cause mortality in chronic hepatitis C (CHC) patients who achieved sustained virological response (SVR) after treatment with dir...

Descripción completa

Detalles Bibliográficos
Autores principales:	Søholm, Jacob, Hansen, Janne Fuglsang, Mössner, Belinda, Røge, Birgit Thorup, Lauersen, Alex, Hansen, Jesper Bach, Weis, Nina, Barfod, Toke Seierøe, Lunding, Suzanne, Øvrehus, Anne, Mohey, Rajesh, Thielsen, Peter, Christensen, Peer Brehm
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7728240/ https://www.ncbi.nlm.nih.gov/pubmed/33301499 http://dx.doi.org/10.1371/journal.pone.0243725

Ejemplares similares

A multi-level intervention to eliminate hepatitis C from the Region of Southern Denmark: the C-Free-South project
por: Dröse, Sandra, et al.
Publicado: (2022)

Nationwide Experience of Treatment with Protease Inhibitors in Chronic Hepatitis C Patients in Denmark: Identification of Viral Resistance Mutations
por: Sølund, Christina, et al.
Publicado: (2014)

Incidence, prevalence and risk factors for hepatitis C in Danish prisons
por: Søholm, Jacob, et al.
Publicado: (2019)

Late Presentation for Care Among Patients With Chronic Hepatitis C: Prevalence and Risk Factors
por: Hansen, Janne Fuglsang, et al.
Publicado: (2017)

Dynamics of APRI and FIB-4 in HCV cirrhotic patients who achieved SVR after DAA therapy
por: Leuştean, Anca, et al.
Publicado: (2021)

Hepatitis C prevalence in Denmark in 2016—An updated estimate using multiple national registers
por: Nielsen, Stine, et al.
Publicado: (2020)

Peripheral PD-1(+) T Cells Co-expressing Inhibitory Receptors Predict SVR With Ultra Short Duration DAA Therapy in HCV Infection
por: Romani, Sara, et al.
Publicado: (2019)

Real life rates of sustained virological response (SVR) and predictors of relapse following DAA treatment in genotype 3 (GT3) patients with advanced fibrosis/cirrhosis
por: Mangia, Alessandra, et al.
Publicado: (2018)

Concordance of SVR12, SVR24 and SVR durability in Taiwanese chronic hepatitis C patients with direct-acting antivirals
por: Lin, Chuan-Pin, et al.
Publicado: (2021)

Treatment of chronic HCV infection with DAAs in Rio de Janeiro/Brazil: SVR rates and baseline resistance analyses in NS5A and NS5B genes
por: Costa, Vanessa D., et al.
Publicado: (2019)

Directly observed therapy at opioid substitution facilities using sofosbuvir/velpatasvir results in excellent SVR12 rates in PWIDs at high risk for non-adherence to DAA therapy
por: Schmidbauer, Caroline, et al.
Publicado: (2021)

Ischemic Heart Disease in Chronic Hepatitis B: A Danish Nationwide Cohort Study
por: Lau, Frederik Faergemann, et al.
Publicado: (2022)

Liver-related morbidity and mortality in patients with chronic hepatitis C and cirrhosis with and without sustained virologic response
por: Hallager, Sofie, et al.
Publicado: (2017)

Feasibility, quality and validity of narrative multisource feedback in postgraduate training: a mixed-method study
por: Holm, Ellen Astrid, et al.
Publicado: (2021)

Incidence of Hepatocellular Carcinoma and Decompensated Liver Cirrhosis and Prognostic Accuracy of the PAGE-B HCC Risk Score in a Low Endemic Hepatitis B Virus Infected Population
por: Bollerup, Signe, et al.
Publicado: (2022)

SVR12 is higher than SVR24 in treatment-naïve hepatitis C genotype 1 patients treated with peginterferon plus ribavirin
por: Thorlund, Kristian, et al.
Publicado: (2014)

Four Weeks Treatment with Glecaprevir/Pibrentasvir + Ribavirin—A Randomized Controlled Clinical Trial
por: Madsen, Lone W., et al.
Publicado: (2022)

Improved CEEMDAN, GA, and SVR Model for Oil Price Forecasting
por: Lu, Yichun, et al.
Publicado: (2022)

Clinical outcomes of DAA and related techniques in hip arthroplasty
por: Driesman, Adam, et al.
Publicado: (2023)

Similar Low Rates of HCV Recurrence in HCV/HIV- and HCV-Infected Participants who Achieved SVR After DAA Treatment: Interim Results From the ACTG A5320 Viral Hepatitis C Infection Long-term Cohort Study (V-HICS)
por: Wyles, David L, et al.
Publicado: (2018)

Ambient Effect Filtering Using NLPCA-SVR in High-Rise Buildings
por: Ye, Xijun, et al.
Publicado: (2020)

1069. Loss to follow-up does not impact SVR for HCV infection
por: Kottilil, Sita K, et al.
Publicado: (2020)

Using High-Frequency Information and RH to Estimate AQI Based on SVR
por: Liaw, Jiun-Jian, et al.
Publicado: (2021)

Characteristics and Survival Outcomes of Hepatocellular Carcinoma Developed after HCV SVR
por: Yeh, Ming-Lun, et al.
Publicado: (2021)

Mixed kernel SVR addressing Parkinson’s progression from voice features
por: Bárcenas, Roberto, et al.
Publicado: (2022)

Study on the spatialization of anthropogenic carbon emissions in China based on SVR-ZSSR
por: Liu, Minghao, et al.
Publicado: (2023)

Retracted: Improved CEEMDAN, GA, and SVR Model for Oil Price Forecasting
por: Environmental and Public Health, Journal of
Publicado: (2023)

Antiretroviral therapy adherence strategies used by patients of a large HIV clinic in Lesotho
por: Axelsson, Johanna Maria, et al.
Publicado: (2015)

Sofosbuvir based treatment of chronic hepatitis C genotype 3 infections—A Scandinavian real-life study
por: Dalgard, Olav, et al.
Publicado: (2017)

Effects of Achieving SVR on Clinical Characteristics and Surgical Outcomes in Patients Who Developed Early-Stage HCV-Related Hepatocellular Carcinoma and Received Curative Resection: Preoperative versus Postoperative SVR
por: Hsu, Po-Yao, et al.
Publicado: (2022)

175 modelos de carpintería /
por: Rodríguez Hernández, Anselmo
Publicado: (1976)

Subject index for volume 175
Publicado: (1990)

Treatment of hepatitis C in HIV patients in the new DAA era
por: Soriano, Vicente
Publicado: (2014)

Baseline and Breakthrough Resistance Mutations in HCV Patients Failing DAAs
por: Paolucci, Stefania, et al.
Publicado: (2017)

Is DAA Treatment Associated with HBV Reactivation? Results from ERCHIVES
por: Butt, Adeel, et al.
Publicado: (2017)

Treatment of hepatitis C virus genotype 4 in the DAA era
por: Di Biagio, Antonio, et al.
Publicado: (2018)

Treatment and re-treatment results of HCV patients in the DAA era
por: Piecha, Felix, et al.
Publicado: (2020)

Persistence of Cryoglobulinemic Vasculitis after DAA Induced HCV Cure
por: Danishwar, Mahmood, et al.
Publicado: (2022)

Coffee intake linked to improved SVR in patients undergoing treatment for hepatitis C
por: McAvoy, Norma C., et al.
Publicado: (2011)

Improved CEEMDAN and PSO-SVR Modeling for Near-Infrared Noninvasive Glucose Detection
por: Li, Xiaoli, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_8jcudqepvnp9n73pmq6uivgi1h